Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal

J Neurosci. 1998 Sep 1;18(17):7033-9. doi: 10.1523/JNEUROSCI.18-17-07033.1998.

Abstract

The nucleus accumbens is a key component of the reward pathway that plays a role in addiction to many drugs of abuse, including psychostimulants and opioids. The effects of withdrawal from chronic morphine were examined in the nucleus accumbens using brain slices from morphine-treated animals. Recordings were made from interneurons in the shell of nucleus accumbens, and the presynaptic inhibition of GABA-A IPSCs by opioids was examined. In slices from control animals, opioids caused a maximal inhibition of 50%, forskolin increased the IPSC amplitude by less than twofold, and the maximal inhibition by opioids in the presence of forskolin was not changed. During withdrawal, however, forskolin caused approximately a fourfold increase in the amplitude of the IPSC, and the maximal inhibition by opioids was increased to 80%. The results indicate that transmitter release is increased during opioid withdrawal, particularly after the activation of adenylyl cyclase. The cAMP-dependent increase in transmitter release is potently inhibited by opioids, such that the overall effect of opioids is augmented during withdrawal. The induction of an opioid-sensitive cAMP-dependent mechanism that regulates transmitter release may be a critical component of acute opioid withdrawal.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenylyl Cyclases / drug effects
  • Analgesics, Opioid / adverse effects*
  • Animals
  • Cyclic AMP / metabolism
  • Enzyme Activation
  • Male
  • Morphine / adverse effects*
  • Neural Inhibition / drug effects*
  • Nucleus Accumbens / drug effects*
  • Nucleus Accumbens / metabolism
  • Patch-Clamp Techniques
  • Phosphodiesterase Inhibitors / pharmacology
  • Presynaptic Terminals / drug effects
  • Rats
  • Rats, Wistar
  • Stimulation, Chemical
  • Substance Withdrawal Syndrome*
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Analgesics, Opioid
  • Phosphodiesterase Inhibitors
  • gamma-Aminobutyric Acid
  • Morphine
  • Cyclic AMP
  • Adenylyl Cyclases